Population-Based Study Finds Increased Risk of Stroke, Heart Attack in Patients With MM
February 23rd 2023Individuals with multiple myeloma were 51% more likely to have a stroke and 36% more likely to have a heart attack compared with the general patient population in a large real-world assessment of arterial thrombotic events among patients with multiple myeloma in the United States.
Read More
Study Confirms Safety, Tolerability of Oral GABA for Type 1 Diabetes
February 23rd 2023A trial enrolling 97 children newly diagnosed with type 1 diabetes did not meet the primary endpoint of preservation of insulin production by beta cells, but it did show a significant decrease in fasting and clinically relevant reduced serum glucagon.
Read More
Similar Survival Rates Seen Among Black African Americans With PMF, Other Groups
February 23rd 2023The study also found, however, that transplant outcomes appear to be worse for Black African American patients who have primary myelofibrosis (PMF), although the study utilized a small sample size.
Read More
Wall Street investors pour money into developing new psychedelic treatments for mental illnesses; extreme temperature fluctuations around the country can pose health risks; Moderna and Merck's combination skin cancer treatment receives breakthrough designation from the FDA.
Read More
How Rising Insulin Costs Impacted Uninsured Populations
February 23rd 2023Researchers looked at trends in insulin usage and expenditure among insured and uninsured populations with diabetes, accounting for how the expansion of Medicaid under the Affordable Care Act may have affected these trends.
Read More
Panel Addresses How Payers, Providers Can Optimally Use Real-World Evidence to Advance Cancer Care
February 23rd 2023Utilizing real-world evidence that applies to the specific care needs of certain patient populations can promote timely decision-making among payers and providers on the use of effective cancer therapies available on the market, said panelists at the 2022 Patient-Centered Oncology Care® (PCOC) meeting.
Read More
Oncolytic Virus Therapy Shows Promising Results in Early-Stage TNBC
February 22nd 2023Results from a phase 2 study suggests that the oncolytic virus talimogene laherparepvec has potential to improve therapy responses for patients undergoing neoadjuvant chemotherapy for triple-negative breast cancer (TNBC).
Read More
Telementoring Program Linked With Improvement in Epilepsy Care Among School Nurses
February 22nd 2023School nurses reported improved knowledge and confidence in the care of students with seizures after undergoing the Project ECHO (Extension for Community Healthcare Outcomes) telementoring program for epilepsy.
Read More
Merck’s COVID-19 pill has been shown to not be successful against household infection risk; the government plans to allow states to use Medicaid funds for prison drug treatment and other services; Ozempic, used to treat type 2 diabetes, is in short supply because it’s being sought for weight loss.
Read More
Andexanet Alfa Fully Neutralizes Anticoagulation From Thrombotic Disorder Treatment
February 22nd 2023Researchers found that the anticoagulant effects of apixaban, betrixaban, edoxaban, and rivaroxaban were partially neutralized at an andexanet alfa dose of 50 mcg/mL and were completely neutralized at 100 mcg/mL.
Read More
Mental Health Care Is Challenged by Inaccurate, Inadequate Provider Directories
February 21st 2023On this episode of Managed Care Cast, we speak with Simon F. Haeder, PhD, MPA, professor of public health at the Texas A&M University School of Public Health. He and his co-investigators looked at the accuracy of directories of psychiatrists and nonphysician mental health providers for all plans regulated by the California Department of Managed Health Care in 2018 and 2019.
Listen
Diagnostic Efficacy of Frequent Acute Exacerbations Investigated in Patients With COPD
February 21st 2023Imaging and clinical characteristics reach high diagnostic efficacy when they are used to identify frequent acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Read More
Joneigh Khaldun, MD, MPH, FACEP, vice president and chief health equity officer for CVS Health, speaks on the goals of the Community Equity Alliance in improving health care disparities, particularly for cardiovascular health and mental health outcomes, within underserved communities.
Watch
Retinal Physicians Report Reservations Around Ophthalmology Biosimilars
February 20th 2023There are 2 ranibizumab biosimilars approved in the United States, and with more ranibizumab and the first aflibercept biosimilars on the horizon, gaps in knowledge among retinal physicians should be addressed.
Read More
Spleen Response Closely Linked With Survival in MF While on Ruxolitinib
February 20th 2023Patients with myelofibrosis (MF) who achieved a spleen response while taking ruxolitinib and lost it had survival outcomes similar to patients who did not respond, according to results from a real-world study.
Read More